TaiMed Biologics Inc. (4147.TWO)
TWD 82.5
(-0.48%)
TWD 82.5
(-0.48%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 491.77 Million TWD | -12.65% |
| 2022 | 563 Million TWD | 36.18% |
| 2021 | 413.44 Million TWD | -42.78% |
| 2020 | 722.48 Million TWD | 2.55% |
| 2019 | 704.5 Million TWD | 192.28% |
| 2018 | 241.04 Million TWD | 2757.29% |
| 2017 | 8.43 Million TWD | 306.36% |
| 2016 | 2.07 Million TWD | 0.0% |
| 2015 | - TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | -100.0% |
| 2011 | 135 Thousand TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 178.94 Million TWD | 13.1% |
| 2024 Q2 | 146.94 Million TWD | -17.89% |
| 2023 Q2 | 104.24 Million TWD | 45.25% |
| 2023 FY | 491.77 Million TWD | -12.65% |
| 2023 Q1 | 71.76 Million TWD | -78.02% |
| 2023 Q4 | 158.21 Million TWD | 0.42% |
| 2023 Q3 | 157.55 Million TWD | 51.14% |
| 2022 Q2 | 99.28 Million TWD | 144.12% |
| 2022 Q1 | 40.67 Million TWD | -46.39% |
| 2022 FY | 563 Million TWD | 36.18% |
| 2022 Q4 | 326.47 Million TWD | 238.04% |
| 2022 Q3 | 96.57 Million TWD | -2.73% |
| 2021 Q4 | 75.85 Million TWD | -16.75% |
| 2021 FY | 413.44 Million TWD | -42.78% |
| 2021 Q1 | 91.26 Million TWD | -40.08% |
| 2021 Q2 | 155.19 Million TWD | 70.06% |
| 2021 Q3 | 91.12 Million TWD | -41.28% |
| 2020 Q1 | 239.19 Million TWD | 14.5% |
| 2020 FY | 722.48 Million TWD | 2.55% |
| 2020 Q2 | 179.05 Million TWD | -25.14% |
| 2020 Q3 | 151.92 Million TWD | -15.15% |
| 2020 Q4 | 152.31 Million TWD | 0.26% |
| 2019 Q4 | 208.9 Million TWD | -1.42% |
| 2019 Q1 | 128.33 Million TWD | 11.6% |
| 2019 Q2 | 155.33 Million TWD | 21.04% |
| 2019 FY | 704.5 Million TWD | 192.28% |
| 2019 Q3 | 211.92 Million TWD | 36.43% |
| 2018 Q2 | 38.41 Million TWD | 0.0% |
| 2018 Q4 | 115 Million TWD | 31.24% |
| 2018 Q3 | 87.62 Million TWD | 128.1% |
| 2018 Q1 | - TWD | -100.0% |
| 2018 FY | 241.04 Million TWD | 2757.29% |
| 2017 Q2 | 2.4 Million TWD | 97.78% |
| 2017 FY | 8.43 Million TWD | 306.36% |
| 2017 Q4 | 2.4 Million TWD | 0.0% |
| 2017 Q1 | 1.21 Million TWD | 95.35% |
| 2017 Q3 | 2.4 Million TWD | -0.04% |
| 2016 FY | 2.07 Million TWD | 0.0% |
| 2016 Q4 | 623 Thousand TWD | 0.0% |
| 2016 Q3 | 623 Thousand TWD | 0.16% |
| 2016 Q2 | 622 Thousand TWD | 199.04% |
| 2016 Q1 | 208 Thousand TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2015 FY | - TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q2 | - TWD | 0.0% |
| 2013 Q3 | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | - TWD | -100.0% |
| 2012 Q3 | - TWD | 0.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2011 FY | 135 Thousand TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 Q2 | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -40610.017% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | -24.142% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -475.38% |
| NaviFUS Corp. | 22.48 Million TWD | -2087.523% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | -171.037% |
| TaiRx, Inc. | 5.08 Million TWD | -9576.84% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -2062.418% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -764.04% |
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -67451.786% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 55.882% |
| AP Biosciences Inc | 32.25 Million TWD | -1424.748% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 70.883% |
| RBC Bioscience Corporation | 172.46 Million TWD | -185.143% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 73.232% |
| EirGenix Inc. | 1.02 Billion TWD | 51.912% |
| Enimmune corporation | 43.49 Million TWD | -1030.678% |
| Lukas Biomedical Inc. | 231.83 Million TWD | -112.126% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -546318.889% |
| 3D Global Biotech Inc. | 20.63 Million TWD | -2283.449% |
| Mycenax Biotech Inc. | 652.62 Million TWD | 24.646% |
| TCI GENE Inc. | 333.85 Million TWD | -47.303% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -2335.022% |
| Oneness Biotech Co., Ltd. | 86.78 Million TWD | -466.674% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | -172.335% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | -659.748% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| Neith Corporation | 39.9 Million TWD | -1132.431% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | -14.68% |
| VBI | 55.85 Million TWD | -780.484% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 35.155% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | -118.122% |
| Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -5063.555% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -60990.311% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -2731994.444% |
| Visgeneer Inc. | 147.99 Million TWD | -232.295% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 38.567% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | -85.77% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | -248.343% |
| Sagittarius Life Science Corp | 440.46 Million TWD | -11.651% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | -347.444% |
| GlycoNex Incorporation | 2.54 Million TWD | -19246.066% |
| Medigen Biotechnology Corp. | 1.15 Billion TWD | 57.522% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | -56.368% |
| PharmaEngine, Inc. | 767.66 Million TWD | 35.939% |
| Intech Biopharm Corporation | 25.84 Million TWD | -1802.646% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | -55.634% |
| BiOptic Inc. | 228.26 Million TWD | -115.437% |
| TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | -299.384% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -49077.7% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | -207.088% |
| OBI Pharma, Inc. | 41.54 Million TWD | -1083.607% |
| Savior Lifetec Corporation | 1.05 Billion TWD | 53.176% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -10039.732% |
| Level Biotechnology Inc. | 660.61 Million TWD | 25.557% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | -26.218% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | -109.854% |
| Acepodia, Inc. | 16.59 Million TWD | -2863.762% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -1163.169% |